Access cutting-edge prostate cancer treatment through this clinical trial at a research site in Stanford. Study-provided care at no cost to qualified participants.
Access prostate cancer specialists in Stanford at no cost
This study follows strict safety protocols and ethical guidelines
All study-related prostate cancer treatment provided free
The aim of this study is to determine the safety and efficacy of 67Cu-SAR-bisPSMA in participants with PSMA-expressing metastatic castrate resistant prostate cancer.
Sponsor: Clarity Pharmaceuticals Ltd
Check if you qualify for this prostate cancer clinical trial in Stanford, CA
If you're searching for prostate cancer treatment options in Stanford, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Stanford research site is actively enrolling participants for this clinical trial. You'll receive care from experienced prostate cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.